Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP): (481832006-001)
The DOI matches its Crossref record.
Abstract
During spring 2005, two tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) products formulated for use in adolescents (and, for one product, use in adults) were licensed in the United States (BOOSTRIX, GlaxoSmithKline Biologicals, Rixensart, Belgium [licensed May 3, 2005, for use in persons aged 10-18 years], and ADACEL, sanofi pasteur, Toronto, Ontario, Canada [licensed June 10, 2005, for use in persons aged 11-64 years]). Prelicensure studies demonstrated safety and efficacy against tetanus, diphtheria, and pertussis when Tdap was administered as a single booster dose to adolescents. To reduce pertussis morbidity in adolescents and maintain the standard of care for tetanus and diphtheria protection, the Advisory Committee on Immunization Practices (ACIP) recommends that: 1) adolescents aged 11-18 years should receive a single dose of Tdap instead of tetanus and diphtheria toxoids vaccine (Td) for booster immunization against tetanus, diphtheria, and pertussis if they have completed the recommended childhood diphtheria and tetanus toxoids and whole cell pertussis vaccine (DTP)/ diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP) vaccination series (five doses of pediatric DTP/DTaP before the seventh birthday; if the fourth dose was administered on or after the fourth birthday, the fifth dose is not needed) and have not received Td or Tdap. The preferred age for Tdap vaccination is 11-12 years; 2) adolescents aged 11-18 years who received Td, but not Tdap, are encouraged to receive a single dose of Tdap to provide protection against pertussis if they have completed the recommended childhood DTP/DTaP vaccination series. An interval of at least 5 years between Td and Tdap is encouraged to reduce the risk for local and systemic reactions after Tdap vaccination. However, an interval less than 5 years between Td and Tdap can be used; and 3) vaccine providers should administer Tdap and tetravalent meningococcal conjugate vaccine (Menactra, sanofi pasteur, Swiftwater, Pennsylvania) to adolescents aged 11-18 years during the same visit if both vaccines are indicated and available. This statement 1) reviews tetanus, diphtheria and pertussis vaccination policy in the United States, with emphasis on adolescents; 2) describes the clinical features and epidemiology of pertussis among adolescents; 3) summarizes the immunogenicity, efficacy, and safety data of the two Tdap vaccines licensed for use among adolescents; and 4) presents recommendations for tetanus, diphtheria, and pertussis vaccination among adolescents aged 11-18 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Munoz, F. M., Bond, N. H., Maccato, M., Pinell, P., Hammill, H. A., Swamy, G. K., Walter, E. B., Jackson, L. A., Englund, J. A., Edwards, M. S., et al. (2014) · JAMA · doi:10.1001/jama.2014.3633 · Cited by 489
Transmission of Bordetella pertussis to Young Infants
Wendelboe, A. M., Njamkepo, E., Bourillon, A., Floret, D. D., Gaudelus, J., Gerber, M., Grimprel, E., Greenberg, D., Halperin, S., Liese, J., et al. (2007) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000258699.64164.6d · Cited by 471
Liang, J. L., Tiwari, T., Moro, P., Messonnier, N. E., Reingold, A., Sawyer, M., & Clark, T. A. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6702a1 · Cited by 457
Self-citationPertussis: Microbiology, Disease, Treatment, and Prevention
Kilgore, P. E., Salim, A. M., Zervos, M. J., & Schmitt, H.-J. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00083-15 · Cited by 434
Omer, S. B., Pan, W. K. Y., Halsey, N. A., Stokley, S., Moulton, L. H., Navar, A. M., Pierce, M., & Salmon, D. A. (2006) · JAMA · doi:10.1001/jama.296.14.1757 · Cited by 387
General Recommendations on Immunization
(1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430010026011 · Cited by 316
Principles of Infectious Diseases: Transmission, Diagnosis, Prevention, and Control
van Seventer, J. M., & Hochberg, N. S. (2017) · International Encyclopedia of Public Health · doi:10.1016/b978-0-12-803678-5.00516-6 · Cited by 298
The Practice of Travel Medicine: Guidelines by the Infectious Diseases Society of America
Hill, D. R., Ericsson, C. D., Pearson, R. D., Keystone, J. S., Freedman, D. O., Kozarsky, P. E., DuPont, H. L., Bia, F. J., Fischer, P. R., & Ryan, E. T. (2006) · Clinical Infectious Diseases · doi:10.1086/508782 · Cited by 296
Adverse reactions to vaccines practice parameter 2012 update
Kelso, J. M., Greenhawt, M. J., Li, J. T., Nicklas, R. A., Bernstein, D. I., Blessing-Moore, J., Cox, L., Khan, D., Lang, D. M., Oppenheimer, J., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.04.003 · Cited by 293
Brewer, N. T., Gottlieb, S. L., Reiter, P. L., McRee, A.-L., Liddon, N., Markowitz, L., & Smith, J. S. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181f12dbf · Cited by 254
Gall, S. A., Myers, J., & Pichichero, M. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.11.024 · Cited by 226
Havers, F. P., Moro, P. L., Hunter, P., Hariri, S., & Bernstein, H. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6903a5 · Cited by 217
Vaccination of special populations: Protecting the vulnerable
Doherty, M., Schmidt-Ott, R., Santos, J. I., Stanberry, L. R., Hofstetter, A. M., Rosenthal, S. L., & Cunningham, A. L. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.11.015 · Cited by 208
Geospatial analysis of nonmedical vaccine exemptions and pertussis outbreaks in the United States
Aloe, C., Kulldorff, M., & Bloom, B. R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700240114 · Cited by 51
Greenberg, D. P., Doemland, M., Bettinger, J. A., Scheifele, D. W., Halperin, S. A., Waters, V., & Kandola, K. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318199d2fc · Cited by 40
Moro, P. L., Arana, J., Marquez, P. L., Ng, C., Barash, F., Hibbs, B. F., & Cano, M. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.04.088 · Cited by 17
Metadata
- Authors
- Broder, K. R., US Department of Health and Human Services, Cortese, M. M., Iskander, J. K., Kretsinger, K., Slade, B. A., Brown, K. H., Mijalski, C. M., Tiwari, T., Weston, E. J., Cohn, A. C., Srivastava, P. U., Moran, J. S., Schwartz, B., & Murphy, T. V.
- Venue
- PsycEXTRA Dataset
- Published
- 2006
- Volume
- 55
- Issue
- RR-3
- Pages
- 1-34
- OpenAlex
- W17864779
- Cited by
- 492
- References
- 0
- Type
- dataset
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.